News: Novozymes Creates Biopharmaceutical Ingredients Business. Genetic Engineering News - Biotechnology from Bench to Business

"Novozymes set up a biopharmaceutical ingredients business to develop and manufacture animal-free recombinant ingredients to support production. The initial focus will be the launch of a range of ingredients developed specifically for industrial-scale mammalian cell culture."